Clinical Trial: The predictive value of Age-Adjusted Charlson Comorbidity Index in the Prognosis of Patients with Esophagogastric Junction Adenocarcinoma Undergoing Radical Surgery (China)

Posted On: 2026-09-10

China, Sept. 10 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'The predictive value of Age-Adjusted Charlson Comorbidity Index in the Prognosis of Patients with Esophagogastric Junction Adenocarcinoma Undergoing Radical Surgery'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600132076

Registration Time: 2026/09/09

Type: Observational study

Primary Sponsor: Chifeng Municipal Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=276771

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: The predictive value of Age-Adjusted Charlson Comorbidity Index in the Prognosis of Patients with Esophagogastric Junction Adenocarcinoma Undergoing Radical Surgery (China)